During the recent J.P. Morgan 44th Annual Healthcare Conference in San Francisco, GEN senior business editor Alex Philippidis and Jonathan Grinstein, PhD, North American editor of GEN sister publication Inside Precision Medicine, took a break from interviewing CEOs, attending corporate presentations, and walking up the city’s famed hills to share some insights about their week at the event—and more broadly, where biopharma now stands and is expected to go in 2026.
Also of Interest
